Navigation Links
Research defines timeframes, factors to deem early stage lung cancer cured
Date:8/2/2010

In patients with non-small cell lung cancer (NSCLC), five-year disease-free survival is currently the benchmark of cure. However, there are two issues that remain with the follow-up standards: (1) When can cure be declared with confidence and (2) for how long should follow-up examination be continued?

In order to define a strategy for long-term follow-up for early stage lung cancer patients, research published in the August edition of the Journal of Thoracic Oncology (JTO) quantified the risk of late recurrence in patients with stage IA NSCLC who remained recurrence-free for more than five years after complete tumor resection. Overall, the findings indicate that in patients with stage IA NSCLC without vascular invasion (cancer cells within blood vessels), five years may be sufficient to declare that the patients are cured. In contrast, patients with stage IA NSCLC with vascular invasion need follow-up until at least nine years after resection.

In this study, the research team identified a total of 519 patients with stage IA NSCLC who underwent complete resection between August 1992 and December 2002. Recurrence-free probability was measured from the benchmark of five years after primary tumor resection to the date of first recurrence or last follow-up. Of the 519 patients, 434 remained recurrence-free for the first five years. Among these, only 21 (4.8 percent) developed late recurrence more than five years after resection.

The researchers identified one independent significant predictor of late recurrence in stage IA five-year recurrence-free survivors: the presence of vascular invasion. The five-year recurrence-free probability from the benchmark was 84 percent for patients with vascular invasion and 95 percent for patients without vascular invasion.

Summarizing the findings, lead investigator, Ryo Maeda, MD, explains that "If they are recurrence-free, patients without vascular invasion may be declared cured at five years after resection. On the other hand, patients with stage IA NSCLC with vascular invasion, five years without recurrence is not sufficient to conclude that NSCLC is cured."


'/>"/>

Contact: Megan Richter
mrichter@spectrumscience.com
202-587-2556
International Association for the Study of Lung Cancer
Source:Eurekalert  

Related medicine news :

1. Women attracted to men in red, research shows
2. Researchers develop advanced search tool to help physicians sort and retrieve vital EMR data
3. Reality TV, cosmetic surgey linked, says Rutgers-Camden researcher
4. MSU targets womens health research with $2.5 million grant
5. Researchers identify key enzyme in DNA repair pathway
6. A breakthrough in tuberculosis research
7. Researchers study benefits of white button mushrooms
8. AWARD Fellowship highlights critical role of African women in agricultural research
9. Use of decision-aid program increases safety for women experiencing abuse, researchers find
10. Trainee publication highlights success of US-China agricultural injury research training project
11. Researchers uncover biological rationale for why intensive lupus treatment works
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Research defines timeframes, factors to deem early stage lung cancer cured
(Date:3/26/2017)... ... March 26, 2017 , ... Local physician Dr. ... Award, a prestigious award honoring the top influencers on RealSelf—the most trusted online ... with doctors and clinics. , In 2016, more than 82 million people visited ...
(Date:3/25/2017)... ... ... Swissray is pleased to announce the release of the ELITE DXA, a new bone ... scan window, which is more than double that of existing bone densitometers. Historically, subjects ... an accurate total body bone density or body composition study. The ELITE DXA ...
(Date:3/24/2017)... ... March 24, 2017 , ... Vighter established its NAEMT ... by providing Prehospital Trauma Life Support (PHTLS) course scholarships to four medics assigned ... education developed in cooperation with the American College of Surgeons to promote critical ...
(Date:3/24/2017)... York, NY (PRWEB) , ... March 24, 2017 ... ... global scale; from third world countries to hospitals in the United States, it’s ... a conversation on the current obstacles facing infection prevention and offers strategies for ...
(Date:3/24/2017)... ... March 24, 2017 , ... The Radiology Business ... Awards . The annual awards, now in their 12th year, are among the most ... winners. , In 2016, the awards were retooled to recognize achievements in both large ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... March 27, 2017 To mark the end of ... Inc., a leader in digital imaging solutions, will showcase Canon ... held at New York,s Jacob Javits ... Vision Month, sponsored by the American Optometric Association, is observed ... of receiving comprehensive eye exams. In recognition of this observance, ...
(Date:3/27/2017)... FinancialBuzz.com News Commentary  ... Based on New Frontier Data,s sales forecasts in 2017, ... will generate $655 million in taxes on retail sales. Out of ... as Washington State,s 37% cannabis retail tax ... taxes that are applied on all retail sales. By 2020, tax ...
(Date:3/27/2017)... 27, 2017   Pulmatrix, Inc . (NASDAQ: PULM), a ... serious pulmonary diseases, today announced that it has added two ... and asthma to its Scientific Advisory Board . ... Richard B. Moss , MD, former chief of the Pediatric ... Fibrosis Center at Stanford University, and ...
Breaking Medicine Technology: